Arterium Corporation launches new probiotic product Probilans
Arterium Corporation is pleased to present Probilans, a new product in the probiotic segment. It is a dietary supplement recommended for patients suffering from an imbalance in intestinal microflora. Intestinal dysbiosis and the ways of rebalancing microflora become increasingly important issues with every passing year. By various estimates, 70–90% of people in different age groups suffer from intestinal dysbiosis nowadays. Probilans is a mixed probiotic developed to help restore and rebalance intestinal microflora.
It is produced in two forms that target different age groups: Probilans capsules are for adults and children over the age of 12 and Probilans sachets – for 1-12-year-old children. The probiotic includes unique strains of normal microflora, their number varying with the pharmaceutical form: the preparation in capsules has 8 strains, and in sachets – 6. The newly-developed ProbioAct protection technology enables the bacteria in Probilans to endure the aggressive environment of the gastrointestinal tract and do their best job in the intestines.
Probilans is recommended for treatment of intestinal microflora alterations, irritable bowel syndrome, and generalised inflammatory bowel conditions as well as to people taking antibiotics, having allergies, transitioning in their alimentary habits, or suffering from stress. Another advantage of Probilans is its storage conditions – it won’t lose its properties even if stored at room temperature (0-25°C).
